Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats.

Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats. Abstract Text:

    haofei xiongHaofei Xiong,bin pengBin Peng,lili weiLili Wei,xiaolei zhangXiaolei Zhang,li wangLi Wang,haofei xiongHaofei Xiong,bin pengBin Peng,lili weiLili Wei,xiaolei zhangXiaolei Zhang,li wangLi Wang,

    The aim of the research was to evaluate the impact of an estrogen-deficient state and alendronate (ALD) therapy on bone loss resulting from experimental periapical lesions in rats. Periapical lesions were induced on ovariectomized (OVX) and sham-ovariectomized (Sham) rats. After sample preparation, histologic and radiographic examination for periapical bone loss area and an enzyme histochemical test for tartrate-resistant acid phosphatase (TRAP) were performed. The results showed that OVX significantly increased bone loss resulting from periradicular lesions. After daily subcutaneous injection of ALD, the bone loss area and the number of TRAP-positive cells (osteoclasts) were reduced. These findings suggested that alendronate may protect against increased bone loss from experimental periapical lesions in estrogen-deficient rats. Given recent recognition of adverse effects of bisphosphonates, including an increased risk for osteonecrosis, the findings from this study should not be interpreted as a new indication for ALD treatment. However, they may offer insight into understanding and predicting outcomes in female postmenopausal patients already on ALD therapy for medical indications.

    Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats. Publishing Authors By Initials

    h xiongH Xiong,b pengB Peng,l weiL Wei,x zhangX Zhang,l wangL Wang,h xiongH Xiong,b pengB Peng,l weiL Wei,x zhangX Zhang,l wangL Wang,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of endodontics

    VOLUME: 33

    Page Numbers: 1304-8

    Journal Abbreviation:

    ISSN: 0099-2399

    DAY: 23

    MONTH: 08

    YEAR: 2007

    Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7511484

    Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats.

    AFFILIATION: Department of Conservative Dentistry and Endodontics, School and Hospital of Stomatology, Wuhan University, Wuhan, Hubei, China.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Endod

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News